🚀 VC round data is live in beta, check it out!
Global Health Valuation Multiples
Discover revenue and EBITDA valuation multiples for Global Health and similar public comparables like Medicover, Aster DM Healthcare, Krishna Institute, Kpj Healthcare and more.
Global Health Overview
About Global Health
Global Health Ltd operates as a private multi-specialty tertiary care provider operating in the North and East regions of India, with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology. Under the Medanta brand, it has a network of hospitals in operation (Gurugram, Indore, Ranchi, and Lucknow), a hospital that is under construction with an operational outpatient facility (Patna), and a hospital (Noida) planned for development. The Group operates Healthcare services as a single business segment in India, constituting a single geographical segment.
Founded
2004
HQ
Employees
9.7K
Website
Sectors
Financials (LTM)
EV
$3B
Global Health Financials
Global Health reported last 12-month revenue of $474M and EBITDA of $100M.
In the same LTM period, Global Health generated $364M in gross profit, $100M in EBITDA, and $59M in net income.
Revenue (LTM)
Global Health P&L
In the most recent fiscal year, Global Health reported revenue of $431M and EBITDA of $103M.
Global Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $474M | XXX | $431M | XXX | XXX | XXX |
| Gross Profit | $364M | XXX | $300M | XXX | XXX | XXX |
| Gross Margin | 77% | XXX | 70% | XXX | XXX | XXX |
| EBITDA | $100M | XXX | $103M | XXX | XXX | XXX |
| EBITDA Margin | 21% | XXX | 24% | XXX | XXX | XXX |
| EBIT Margin | 17% | XXX | 19% | XXX | XXX | XXX |
| Net Profit | $59M | XXX | $60M | XXX | XXX | XXX |
| Net Margin | 13% | XXX | 14% | XXX | XXX | XXX |
| Net Debt | — | — | $11M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Global Health Stock Performance
Global Health has current market cap of $3B, and enterprise value of $3B.
Market Cap Evolution
Global Health's stock price is $12.65.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3B | $3B | 0.4% | XXX | XXX | XXX | $0.22 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialGlobal Health Valuation Multiples
Global Health trades at 7.1x EV/Revenue multiple, and 33.8x EV/EBITDA.
EV / Revenue (LTM)
Global Health Financial Valuation Multiples
As of March 7, 2026, Global Health has market cap of $3B and EV of $3B.
Equity research analysts estimate Global Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Global Health has a P/E ratio of 57.3x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $3B | XXX | $3B | XXX | XXX | XXX |
| EV (current) | $3B | XXX | $3B | XXX | XXX | XXX |
| EV/Revenue | 7.1x | XXX | 7.8x | XXX | XXX | XXX |
| EV/EBITDA | 33.8x | XXX | 32.6x | XXX | XXX | XXX |
| EV/EBIT | 42.4x | XXX | 41.2x | XXX | XXX | XXX |
| EV/Gross Profit | 9.2x | XXX | 11.2x | XXX | XXX | XXX |
| P/E | 57.3x | XXX | 56.4x | XXX | XXX | XXX |
| EV/FCF | 254.5x | XXX | 429.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Global Health Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Global Health Margins & Growth Rates
Global Health's revenue in the last 12 month grew by 15%.
Global Health's revenue per employee in the last FY averaged $0.0M.
Global Health's rule of 40 is 36% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Global Health's rule of X is 57% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Global Health Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 15% | XXX | 11% | XXX | XXX | XXX |
| EBITDA Margin | 21% | XXX | 24% | XXX | XXX | XXX |
| EBITDA Growth | 24% | XXX | (4%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 36% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 57% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 1% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 15% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 0% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 51% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Global Health Public Comps
See public comps and valuation multiples for other Hospitals & Clinics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Medicover | XXX | XXX | XXX | XXX | XXX | XXX |
| Aster DM Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Krishna Institute | XXX | XXX | XXX | XXX | XXX | XXX |
| Kpj Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Mouwasat | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Global Health M&A Activity
Global Health acquired XXX companies to date.
Last acquisition by Global Health was on XXXXXXXX, XXXXX. Global Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Global Health
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialGlobal Health Investment Activity
Global Health invested in XXX companies to date.
Global Health made its latest investment on XXXXXXXX, XXXXX. Global Health invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Global Health
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Global Health
| When was Global Health founded? | Global Health was founded in 2004. |
| Where is Global Health headquartered? | Global Health is headquartered in India. |
| How many employees does Global Health have? | As of today, Global Health has over 9K employees. |
| Who is the CEO of Global Health? | Global Health's CEO is Pankaj Sahni. |
| Is Global Health publicly listed? | Yes, Global Health is a public company listed on National Stock Exchange of India. |
| What is the stock symbol of Global Health? | Global Health trades under MEDANTA ticker. |
| When did Global Health go public? | Global Health went public in 2022. |
| Who are competitors of Global Health? | Global Health main competitors are Medicover, Aster DM Healthcare, Krishna Institute, Kpj Healthcare. |
| What is the current market cap of Global Health? | Global Health's current market cap is $3B. |
| What is the current revenue of Global Health? | Global Health's last 12 months revenue is $474M. |
| What is the current revenue growth of Global Health? | Global Health revenue growth (NTM/LTM) is 15%. |
| What is the current EV/Revenue multiple of Global Health? | Current revenue multiple of Global Health is 7.1x. |
| Is Global Health profitable? | Yes, Global Health is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Global Health? | Global Health's last 12 months EBITDA is $100M. |
| What is Global Health's EBITDA margin? | Global Health's last 12 months EBITDA margin is 21%. |
| What is the current EV/EBITDA multiple of Global Health? | Current EBITDA multiple of Global Health is 33.8x. |
| What is the current FCF of Global Health? | Global Health's last 12 months FCF is $13M. |
| What is Global Health's FCF margin? | Global Health's last 12 months FCF margin is 3%. |
| What is the current EV/FCF multiple of Global Health? | Current FCF multiple of Global Health is 254.5x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.